Six Years, One Forged Pad: Ruti Aga and the Broken Medical Governance of the Marathon

When Ruti Aga crossed the finish line of the 2026 Tokyo Marathon in 2:20:40, she already had Beijing, Berlin and Chicago podium finishes behind her — a marathoner with three World Marathon Major second places and one major title. Five years later, in a Thursday statement, the Athletics Integrity Unit confirmed that the same runner would serve a six-year ban. The cause: a forged prescription issued by a family member who was not a doctor. The positive sample came after she won a half marathon in China in March. The substance was methylprednisolone. Media reports labelled it a 'prohibited steroid,' which is technically wrong. It is a glucocorticoid, WADA class S9, prohibited in-competition only. It is the same drug used routinely for knee inflammation, from rural Indian clinics to Kenyan altitude camps. But the real information value of this case sits not in the substance. It sits in the system that produced a fake clinic and a fake doctor to hide it.

At the Kalinga Stadium during the 2026 Asian Athletics Championships, I saw for the first time how an athlete's medical support decides her livelihood more than her performance does. There were ninety reporters in that mixed zone and two women. I was one of them. A Railways-employed quarter-miler stood in front of me, paid her own physio out of a 28,000-rupee salary, and I started a private coverage ledger that day — one line after every meet: who funds this athlete? Aga's case is the larger version of the same question. Not what she took, but why she did not have a real medical record to put before the panel.

The arithmetic: two plus four

According to the AIU statement, the six-year sanction is a sum of two violations. Presence of a prohibited substance: two years. That is the default for a specified substance when intent to cheat is not proven. Tampering during the investigation: four years. This is the Code's standard sanction for a forged document or a misleading statement. Two and four, six. The arithmetic tells us the panel found the presence violation proven and the tampering fully culpable. The route to any mitigation requires the athlete to show the fault was not hers. The forged prescription closed that route itself.

The ban starts from 10 September, the date of provisional suspension — backdated, as is standard. This gives the athlete no real benefit. Six years on, she will be nearly 38. Ethiopia's women's marathon depth is such that a 38-year-old returning with a doping record would not be selectable.

The result and prize money from that March half marathon will almost certainly be voided, even though the article does not say so. Standard AIU practice is automatic disqualification of the competition where the sample was collected, plus forfeiture of ranking points accrued after that date. The 2026 Tokyo title and the three Major podiums predate the scope of the charge. Unless earlier use is proven, those marks stay in the record book. In ledger terms, they are no longer assets you can sell; in athletics history, they remain.

The most instructive part is how the lie was caught. Four separate verification failures in the AIU investigation, each pointing to a different institutional weakness. First: the clinic named on the prescription did not exist. Second: the person who signed it had no medical registration — a family member. Third: that person claimed they had used an 'old prescription pad from a former workplace.' That claim collapsed because the clinic named on the pad explicitly disowned it. Fourth: the athlete's own investigative interview statement did not match the document. No TUE. No proper documentation of the injection.

The knee injury was not a hollow excuse. Chronic knee pathology is common in marathoners. Intra-articular or peri-articular methylprednisolone for synovitis is standard sports-medicine practice. Such an injection is usually given out of competition so that swelling subsides and pain eases. The rules say S9 substances are prohibited in-competition only, so an injection given at the right time and by the right route should clear out before competition. The real problem was that the athlete had no valid medical record of that injection. When asked, a forged document was produced. That lie converted a substance violation into documentary tampering.

The media error, and its consequences

In reports that labelled methylprednisolone a 'prohibited steroid,' the whole case was put in the wrong frame. Anabolic steroids (S1) and glucocorticoids (S9) are entirely different. Anabolic steroids build muscle. Glucocorticoids reduce inflammation and relieve pain. That is why WADA prohibits glucocorticoids only in-competition. If an athlete had an injection days before competition and the substance has cleared the body, that is not a violation. That was the legal route Aga could have taken.

For a 2:18-level marathoner, an int-articular knee injection should wash out in three to four days. If the team had real medical records, they could have been declared. But if the actual injection was taken so close to competition that residues remained on race day, that is a different matter. The media's technical description blurred the line between both situations.

The structure changed, the name didn't

Ruti Aga's case is not one athlete's mistake. It is a picture of the East African road-racing economy, where an informal medical network operates around the runner. Managers, trainers, local clinics and the 'family doctor' — a system where people substitute for each other to save money. For athletes who usually receive a large appearance fee before every major, depending on that network is easy. When injury strikes, sitting out of competition is financially expensive. That is why medical paperwork is often created after the fact.

The message to the Asian label-race circuit is clear. Chinese road races have offered large appearance fees in recent years — and AIU testing is picking up. Aga's positive sample came from a March half marathon in China, a sign that AIU is now watching this road-race economy tier more closely.

The question is not the drug, it's the paper

The most striking fact of this entire episode is that the root of the ban is not the substance found in the blood. It is the paper that was proven fake. If proper medical records had existed, the case might have been reduced to a two-year suspension, or not built at all. Instead, the athlete chose a route that took her out of the system entirely. That is the lesson that matters for Indian athletes too, where knee and shoulder injection records are often not kept in writing.

Looking at AIU decisions over the past few years, a pattern emerges. After an initial positive test, when the athlete is asked for an explanation, a forged document often appears with it. The first two-year case becomes a four-year case, and the total sanction climbs to six. This is not just Ruti Aga's story; it is the story of a system where there is no legitimate route to injury treatment and athletes are pushed to take risks.

The solution is not harsher sanctions alone. The real need is a legitimate medical support system at every level of the sport — where every drug, from knee injections onward, is recorded and can be presented to the AIU. Until that system exists, such cases will keep coming, and each time a new talent will be caught in the paper trap and forced out.

The bigger question: should an athlete who won the Tokyo Marathon have to end her career simply because she lacked the right medical record to show a knee injection? For the AIU, the answer is clear: the rules apply equally to drugs and to documents. But for the sporting world, the question remains open. Before judging the medicine used for an injury and its pre-competition effects, athletes need a helpline that does not sit within the investigative net — one that shows the right path from the start. We need a medical adviser who can tell athletes, before the AIU investigation begins, how to time, administer and document a knee injection — so no one else falls into this trap.

Until that day comes, such stories will keep coming. The athlete's name will be there. The entire medical economy behind her will be missing. Ruti Aga's six-year ban is not just a ruling. It is a warning to a system that still fails to protect its players.